These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10237259)

  • 21. Institutional Review Board policies and procedures provide protection for human research subjects and hospitals.
    Reynolds MB
    Health Care Law Newsl; 1992 Sep; 7(9):7-11. PubMed ID: 10123075
    [No Abstract]   [Full Text] [Related]  

  • 22. More tales from institutional review boards.
    Neuhauser D
    Health Matrix Clevel; 1994; 4(1):153-8. PubMed ID: 10142174
    [No Abstract]   [Full Text] [Related]  

  • 23. Medical lasers and the law.
    Norton ML; Norton EV
    Leg Med; 1986; ():134-47. PubMed ID: 3312887
    [No Abstract]   [Full Text] [Related]  

  • 24. DHHS human subjects protection: the new regulations revisited.
    Grunder TM
    Health Matrix; 1983; 1(2):37-41. PubMed ID: 10263330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The history of institutional review boards.
    Sherman M; Van Vleet JD
    Regul Aff J; 1991; 3():615-27. PubMed ID: 11651491
    [No Abstract]   [Full Text] [Related]  

  • 26. Medical research oversight from the corporate governance perspective: comparing institutional review boards and corporate boards.
    Saver RS
    William Mary Law Rev; 2004 Nov; 46(2):619-730. PubMed ID: 17167924
    [No Abstract]   [Full Text] [Related]  

  • 27. [Variation and inconsistency in the evaluation of experiments by medical ethics committees].
    Bergkamp L
    Ned Tijdschr Geneeskd; 1989 Mar; 133(9):446-9. PubMed ID: 2710252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. View from the Nation's Capitol.
    Freishtat HW
    J Clin Psychopharmacol; 1982 Apr; 2(2):146-8. PubMed ID: 6926924
    [No Abstract]   [Full Text] [Related]  

  • 29. Challenges in human subject protection.
    Nightingale SL
    Food Drug Law J; 1995; 50(4):493-501. PubMed ID: 10343016
    [No Abstract]   [Full Text] [Related]  

  • 30. Institutional review boards and approval of new products without human subjects research.
    Maloney DM
    Hum Res Rep; 2002 Jul; 17(7):1-2. PubMed ID: 12731489
    [No Abstract]   [Full Text] [Related]  

  • 31. Research infrastructure and IRB/FDA requirements.
    Cohen J
    Med Health R I; 2000 Dec; 83(12):382-5. PubMed ID: 11190124
    [No Abstract]   [Full Text] [Related]  

  • 32. Protecting "human guinea pigs".
    Thompson RC
    FDA Consum; 1986 Dec-1987 Jan; 20(10):12-5. PubMed ID: 10311766
    [No Abstract]   [Full Text] [Related]  

  • 33. Research involving children: regulations, review boards and reform.
    Gandhi R
    J Health Care Law Policy; 2005; 8(2):264-330. PubMed ID: 16471026
    [No Abstract]   [Full Text] [Related]  

  • 34. What's new with institutional review boards?
    Stone PW
    Appl Nurs Res; 2001 Aug; 14(3):171-2. PubMed ID: 11481596
    [No Abstract]   [Full Text] [Related]  

  • 35. The impact of institutional review boards on clinical research.
    Levine RJ
    Perspect Biol Med; 1980 Pt 2): S99-S114, Winter; 23(2):. PubMed ID: 11663073
    [No Abstract]   [Full Text] [Related]  

  • 36. Regulatory overview: protection of human subjects--IRBS and informed consent.
    Nightingale SL
    Drug Inf J; 1987; 21(2):109-15. PubMed ID: 10282111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Institutional review boards and institutions not doing enough to protect human subjects.
    Maloney DM
    Hum Res Rep; 2000 Jun; 15(6):1-3. PubMed ID: 12199292
    [No Abstract]   [Full Text] [Related]  

  • 38. Position statement of the AFCR on FDA proposal to assign scientific review of new drugs for human use to local institutional review boards.
    American Federation for Clinical Research
    Clin Res; 1982 Feb; 30(1):27-8. PubMed ID: 11653562
    [No Abstract]   [Full Text] [Related]  

  • 39. Protection of human subjects; proposed establishment of regulations.
    Fed Regist; 1979 Apr; 44(80):24106-11. PubMed ID: 10241036
    [No Abstract]   [Full Text] [Related]  

  • 40. FDA's proposed rules for institutional review boards.
    Hendrix TR
    J Med Educ; 1979 Dec; 54(12):961-3. PubMed ID: 513103
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.